TY - JOUR
T1 - Hepatic enzyme induction with phenobarbital and doxorubicin metabolism and myelotoxicity in the rabbit
AU - Sturgill, Marc G.
AU - August, David A.
AU - Brenner, Dean E.
PY - 2000
Y1 - 2000
N2 - Doxorubicin (DOX) undergoes extensive liver metabolism. This study was designed to compare the pharmacokinetic and myelotoxicity profiles of DOX and metabolites with and without phenobarbital-associated hepatic enzyme induction. DOX was administered i.v. to eight rabbits with and without 7 prior days of oral phenobarbital, with venous blood samples collected between 0 and 72 hr for determination of plasma DOX and metabolite concentrations by high-performance liquid chromatography and complete blood counts obtained on days 1, 5, 7, 8, and 9. DOX AUC(∞), t(1/2β) and CL(T) values were significantly reduced by phenobarbital induction (PBI), while only the formation clearance of DOX metabolites was significantly changed. PBI had no effect on nadir neutrophil counts but was associated with significantly accelerated neutrophil recovery. Hepatic enzyme induction with phenobarbital significantly reduces plasma DOX exposure while increasing the rate of metabolite formation. These effects result in significant acceleration of neutrophil recovery.
AB - Doxorubicin (DOX) undergoes extensive liver metabolism. This study was designed to compare the pharmacokinetic and myelotoxicity profiles of DOX and metabolites with and without phenobarbital-associated hepatic enzyme induction. DOX was administered i.v. to eight rabbits with and without 7 prior days of oral phenobarbital, with venous blood samples collected between 0 and 72 hr for determination of plasma DOX and metabolite concentrations by high-performance liquid chromatography and complete blood counts obtained on days 1, 5, 7, 8, and 9. DOX AUC(∞), t(1/2β) and CL(T) values were significantly reduced by phenobarbital induction (PBI), while only the formation clearance of DOX metabolites was significantly changed. PBI had no effect on nadir neutrophil counts but was associated with significantly accelerated neutrophil recovery. Hepatic enzyme induction with phenobarbital significantly reduces plasma DOX exposure while increasing the rate of metabolite formation. These effects result in significant acceleration of neutrophil recovery.
UR - http://www.scopus.com/inward/record.url?scp=0034100994&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034100994&partnerID=8YFLogxK
U2 - https://doi.org/10.3109/07357900009031824
DO - https://doi.org/10.3109/07357900009031824
M3 - Article
C2 - 10754988
SN - 0735-7907
VL - 18
SP - 197
EP - 205
JO - Cancer Investigation
JF - Cancer Investigation
IS - 3
ER -